Market Cap 193.21M
Revenue (ttm) 4.71M
Net Income (ttm) -58.01M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,231.63%
Debt to Equity Ratio 2.19
Volume 625,800
Avg Vol 756,056
Day's Range N/A - N/A
Shares Out 177.25M
Stochastic %K 41%
Beta 1.10
Analysts Strong Sell
Price Target $4.10

Company Profile

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. The company's flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths t...

Industry: Medical Devices
Sector: Healthcare
Phone: 917 813 1828
Address:
360 Madison Avenue, 25th Floor, New York, United States
tds_
tds_ May. 5 at 11:41 PM
$LUCD any day now would be good to save some more lives…
0 · Reply
Shabbaman
Shabbaman May. 5 at 11:17 PM
0 · Reply
theDailyMatters
theDailyMatters May. 5 at 9:27 PM
$LUCD UBS Group AG reports 43.94% increase in ownership of LUCD / Lucid Diagnostics Inc https://fintel.io/so/us/lucd/ubs More!
1 · Reply
thingkfast
thingkfast May. 5 at 6:44 PM
$LUCD honest question, why do I money parked here when AI memory names are going to run for a decade plus?
1 · Reply
Carter113
Carter113 May. 5 at 5:18 PM
$LUCD $PAVM from DDW this week in Chicago, Guidelines supporting EsoGuard by name. Highest level of evidence!!!
1 · Reply
RetiredMD
RetiredMD May. 4 at 8:22 PM
$LUCD What this study is basically saying is that EsoGuard is a better screening modality than endoscopy: "...But a major new study suggests the earliest clues to the most common form of esophageal cancer can linger even when doctors can’t spot the usual red flag during an exam." "...Researchers analyzing thousands of patients report that Barrett’s esophagus, a precancerous change in the lining of the esophagus, appears to sit behind all cases of esophageal adenocarcinoma, even when Barrett’s is no longer visible on endoscopy." "...The finding, published in Nature Medicine, could sharpen screening strategies by pushing medicine toward minimally invasive tests that look for molecular “breadcrumbs,” not just visible lesions." https://www.ecoticias.com/en/the-early-warning-signs-of-esophageal-cancer-may-be-hiding-in-everyday-discomfort-and-scientists-warn-that-what-looks-like-routine-reflux-could-arrive-much-earlier-than-expected/31624/
3 · Reply
DrKyle
DrKyle May. 4 at 4:13 PM
$LUCD where does Caris Life Sciences relate to the timeline? When was their CAC meeting?
6 · Reply
theDailyMatters
theDailyMatters May. 4 at 2:45 PM
$LUCD are they about to have another conference call, and no update from MolDx? Darn.
1 · Reply
trout290zzaam
trout290zzaam May. 4 at 12:32 PM
$LUCD $PAVM Are we in a news vacuum?
1 · Reply
ShaolinViolin23
ShaolinViolin23 May. 3 at 10:14 PM
$LUCD i had a dream, fellas this is our week! 😂
2 · Reply
Latest News on LUCD
Lucid Diagnostics Earnings Call Transcript: Q4 2025

Mar 26, 2026, 8:30 AM EDT - 5 weeks ago

Lucid Diagnostics Earnings Call Transcript: Q4 2025


Lucid Diagnostics Earnings Call Transcript: Q3 2025

Nov 12, 2025, 8:30 AM EST - 6 months ago

Lucid Diagnostics Earnings Call Transcript: Q3 2025


Lucid Diagnostics Transcript: Status Update

Sep 8, 2025, 8:30 AM EDT - 8 months ago

Lucid Diagnostics Transcript: Status Update


Lucid Diagnostics Earnings Call Transcript: Q2 2025

Aug 13, 2025, 8:30 AM EDT - 9 months ago

Lucid Diagnostics Earnings Call Transcript: Q2 2025


Lucid Diagnostics Transcript: AGM 2025

Jun 18, 2025, 11:00 AM EDT - 11 months ago

Lucid Diagnostics Transcript: AGM 2025


Lucid Diagnostics Earnings Call Transcript: Q1 2025

May 14, 2025, 8:30 AM EDT - 1 year ago

Lucid Diagnostics Earnings Call Transcript: Q1 2025


Lucid Diagnostics Earnings Call Transcript: Q4 2024

Mar 24, 2025, 8:30 AM EDT - 1 year ago

Lucid Diagnostics Earnings Call Transcript: Q4 2024


tds_
tds_ May. 5 at 11:41 PM
$LUCD any day now would be good to save some more lives…
0 · Reply
Shabbaman
Shabbaman May. 5 at 11:17 PM
0 · Reply
theDailyMatters
theDailyMatters May. 5 at 9:27 PM
$LUCD UBS Group AG reports 43.94% increase in ownership of LUCD / Lucid Diagnostics Inc https://fintel.io/so/us/lucd/ubs More!
1 · Reply
thingkfast
thingkfast May. 5 at 6:44 PM
$LUCD honest question, why do I money parked here when AI memory names are going to run for a decade plus?
1 · Reply
Carter113
Carter113 May. 5 at 5:18 PM
$LUCD $PAVM from DDW this week in Chicago, Guidelines supporting EsoGuard by name. Highest level of evidence!!!
1 · Reply
RetiredMD
RetiredMD May. 4 at 8:22 PM
$LUCD What this study is basically saying is that EsoGuard is a better screening modality than endoscopy: "...But a major new study suggests the earliest clues to the most common form of esophageal cancer can linger even when doctors can’t spot the usual red flag during an exam." "...Researchers analyzing thousands of patients report that Barrett’s esophagus, a precancerous change in the lining of the esophagus, appears to sit behind all cases of esophageal adenocarcinoma, even when Barrett’s is no longer visible on endoscopy." "...The finding, published in Nature Medicine, could sharpen screening strategies by pushing medicine toward minimally invasive tests that look for molecular “breadcrumbs,” not just visible lesions." https://www.ecoticias.com/en/the-early-warning-signs-of-esophageal-cancer-may-be-hiding-in-everyday-discomfort-and-scientists-warn-that-what-looks-like-routine-reflux-could-arrive-much-earlier-than-expected/31624/
3 · Reply
DrKyle
DrKyle May. 4 at 4:13 PM
$LUCD where does Caris Life Sciences relate to the timeline? When was their CAC meeting?
6 · Reply
theDailyMatters
theDailyMatters May. 4 at 2:45 PM
$LUCD are they about to have another conference call, and no update from MolDx? Darn.
1 · Reply
trout290zzaam
trout290zzaam May. 4 at 12:32 PM
$LUCD $PAVM Are we in a news vacuum?
1 · Reply
ShaolinViolin23
ShaolinViolin23 May. 3 at 10:14 PM
$LUCD i had a dream, fellas this is our week! 😂
2 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser May. 2 at 3:31 AM
$LUCD RSI: 36.99, MACD: -0.0500 Vol: 0.11, MA20: 1.18, MA50: 1.27 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
RetiredMD
RetiredMD May. 2 at 2:51 AM
$LUCD Just a quick reminder: “As of early 2026, there are approximately 69.9 million total Medicare beneficiaries in the United States. This number continues to grow by roughly 100,000 people per month as an average of 10,000 Americans turn 65 every day” “Based on clinical guidelines from major gastroenterology societies, it is estimated that approximately 13.4% to 22.1% of Medicare beneficiaries with chronic GERD should be screened for esophageal cancer” 70 million x 13% = 9.1 million 70 million x 22% = 15.4 million 9-15+ million customers in the VERY near future
1 · Reply
oaksapollo
oaksapollo May. 2 at 2:37 AM
0 · Reply
trout290zzaam
trout290zzaam May. 2 at 2:11 AM
$LUCD Well, that’s that.
0 · Reply
oaksapollo
oaksapollo May. 1 at 8:34 PM
$LUCD I could be wrong, but 95% certain our investor who took the 15M shares in last week's financing has bout 5 hours to disclose their position. They had 5 days, but now down to 5 hours. Will post it if I see it.
5 · Reply
Investbythenumbers
Investbythenumbers May. 1 at 3:41 PM
$LUCD It’s not about timing the market — it’s about time in the market! LUCD has real technology in cancer prevention diagnostics and massive long-term potential as they scale commercially. Short-term noise and volatility? Expected in a name like this. But if you’re positioned with conviction, patience rewards those who stay the course. Loading up on dips and holding for the bigger picture.
4 · Reply
BigJuicy
BigJuicy May. 1 at 5:31 AM
$LUCD may 21 or 28? When are we getting our cookie? $PAVM
3 · Reply
oaksapollo
oaksapollo Apr. 30 at 8:25 PM
$LUCD I have a hunch: 1) Deal closed last Fri, investor at 15M shares is over 5%, they need to file within 5 business days (tomorrow). 2) I suspect they haven't filed because they are patiently buying on the open market at these bargain basement prices that THEY CREATED. I checked, there is no standstill. 3) Tomorrow, I think we will start to see the price appreciate as they are running out of time to complete their position before the filing deadline (buying gets more urgent). 4) After close tomorrow, we see a schedule 13G disclosing their full position, the 15M from the offering and whatever they bought this week. If I'm right about this, it's really a brilliant move by this investor. The terms of the deal enabled them to get a huge block of 15M shares at a 23% discount to market, plus a full week of additional open market buys, still at a heavily discounted price. I'm glad we have smart investors but also...COME ON MAN. Stop diluting my position!
2 · Reply
KYLE0829
KYLE0829 Apr. 30 at 2:04 PM
$LUCD what am I missing? Thought they already had a call to discuss Q1? PR out about another call to discuss Q1 on 5/14? Says business update also. Seems strange. Guess it can’t get much worse
3 · Reply
PortfolioMgmt23
PortfolioMgmt23 Apr. 30 at 1:39 PM
$LUCD I'd love to see some insider buys right now.
1 · Reply
oaksapollo
oaksapollo Apr. 30 at 11:30 AM
$LUCD No draft for us, but also no other new LCDs, so it's not like they dropped a bunch of important docs and we didn't make the cut. If you look at the 3 LCD's posted last night, they're fixing broken hyperlinks and grammatical errors (nothing new). Palmetto posted zero docs, which I think means a draft next week is a good possibility. I'm trying not to trash Moldx but man, it's getting harder and harder.
0 · Reply
theDailyMatters
theDailyMatters Apr. 30 at 10:37 AM
$LUCD sites up, no LCD.
1 · Reply